FDA classifies action as Class I
The U.S. Food and Drug Administration (FDA) has classified Medtronic’s recent voluntary recall of its HeartWare HVAD System as Class I, which the agency defines as “a situation in which there is a reasonable probability that the use of or exposure to a violative product will cause serious adverse health consequences or death.”